The Evidence Trail

Open the black box

Walk through how the platform turns an uploaded medical history into a clinician-ready longevity profile — every line traceable to cited clinical evidence.

Structured sections
7
Parsed from one uploaded history
Longevity domains
5
Objectives + tracked markers
Safety flag surfaced
1
G6PD medication/exposure risk
Unsupported claims
0
Every statement traceable to source

An anonymized case, step by step

A real longevity profile, de-identified. Expand each step to see what the system works with — from raw upload to safety flags and cited evidence.

The profile it generates

Not a chat transcript — a clinician-ready, medical-grade document. Here is the full case rendered as the exported profile a physician receives.

Everything below is reproduced in the downloadable report — the same medical-grade PDF export a clinician receives, fully de-identified.

Download sample report (PDF)

Integrative Medicine AI

Medical History & Longevity Optimization Profile

Sample · De-identified
Patient
Sample Patient
Age
47 years
Focus
Longevity & healthspan optimization
Prepared
Prepared May 2026

1 · Clinical snapshot

  • Primary goal: optimize healthspan, longevity, function, and prevention rather than treat an active illness.
  • No reported chronic medical illness, prior surgery, or hospitalization.
  • Known G6PD deficiency should remain visible in the medical chart.
  • No known drug, food, environmental, or latex allergies reported.

2 · Medical history

General health

Reported: Healthy adult by report.

Chart note: Longevity-focused preventive care.

G6PD deficiency

Reported: Known history of glucose-6-phosphate dehydrogenase deficiency.

Chart note: Medication and exposure flag; not an allergy.

Cardiovascular / metabolic

Reported: No known history reported.

Chart note: No known coronary disease, stroke, heart failure, hypertension, diabetes, thyroid disease, or metabolic disorder reported.

Cancer

Reported: No known history reported.

Chart note: No malignancy history reported.

Pulmonary / renal / hepatic / neurologic

Reported: No known history reported.

Chart note: No chronic lung, kidney, liver, seizure, stroke, or neurodegenerative disorder reported.

Autoimmune / inflammatory

Reported: No known history reported.

Chart note: No autoimmune diagnosis reported.

3 · Surgical history, allergies & medications

Surgical historyNone reported.
HospitalizationsNone reported.
Drug allergiesNo known drug allergies reported.
Food / environmental / latex allergiesNone reported.
Prescription medicationsNone listed in this summary; verify at clinical intake.
OTC medications / supplementsNone listed; document product, dose, frequency, start date, reason for use, and adverse effects if used.

4 · Safety flag

G6PD deficiency

Medication / exposure flag — not an allergy

G6PD deficiency is not an allergy, but it can matter when selecting medications or evaluating symptoms such as sudden fatigue, jaundice, dark urine, pallor, shortness of breath, or unexplained anemia. The patient should tell clinicians, dentists, urgent-care clinicians, and pharmacists about G6PD deficiency before starting new medications. Medication-avoidance lists and severity interpretation should be confirmed by a licensed clinician.

5 · Family, social & lifestyle history

Family history

Not provided.

Suggested at visit: Document premature cardiovascular disease, diabetes, cancer, dementia, autoimmune disease, kidney disease, and inherited blood/enzyme disorders.

Nutrition / exercise

Not specified.

Suggested at visit: Track dietary pattern, protein, fiber, aerobic fitness, strength, mobility, balance, injury history, and recovery.

Sleep / stress

Not specified.

Suggested at visit: Track sleep duration, consistency, snoring, daytime sleepiness, chronic stress load, and recovery practices.

Substances / exposures

Not specified.

Suggested at visit: Document tobacco/nicotine, alcohol, cannabis/recreational substances, occupational exposures, and environmental exposures if relevant.

6 · Longevity optimization framework

Cardiometabolic

Reduce long-term cardiovascular and metabolic risk.

Track: Blood pressure, body composition, lipid profile, glucose markers, liver/kidney markers; ApoB/Lp(a) if appropriate.

Cancer prevention

Stay current on age-appropriate screening.

Track: Colorectal screening, skin exam, oral/dental care, and sex-specific screening as appropriate.

Brain & sleep health

Preserve cognition, mood, sleep quality, and vascular brain health.

Track: Sleep, hearing/vision, exercise, mood, cognitive baseline if clinically useful.

Musculoskeletal

Maintain strength, mobility, bone health, and injury resilience.

Track: Resistance training, mobility, balance, pain/injury review, and bone-health risk review.

Medication & supplement safety

Avoid preventable interactions and G6PD-relevant risks.

Track: Maintain a reconciled list of prescriptions, OTC drugs, supplements, hormones, peptides, and nootropics.

7 · Active problem list & summary

  1. 1G6PD deficiency — known chart flag; no complications reported in this history.
  2. 2No chronic illness reported — healthy adult, longevity-focused.
Summary — This 47-year-old adult reports being generally healthy and is optimizing for longevity and healthspan. Medical history is notable for known G6PD deficiency only. The patient reports no chronic illnesses, no prior surgeries, and no known allergies. Preventive care should focus on risk-factor monitoring, age-appropriate screening, functional health, and careful medication/supplement reconciliation with attention to G6PD-related precautions.
Patient-reported summary for clinical discussion; clinician verification required. Not a substitute for a clinician-verified medical record.

Sample, de-identified. A real profile generated by the platform with the patient name and all direct identifiers removed.

How evidence scoring works

Every claim carries an evidence tier and a quality score from 0 to 1. Higher-tier evidence is weighted more heavily during retrieval and reasoning; claims below threshold are suppressed before they ever reach the clinician.

Meta-analysis / Systematic Review0.90 – 1.00
Randomized Controlled Trial0.75 – 0.95
Cohort / Observational0.55 – 0.80
Case Study / Series0.35 – 0.60
Expert Opinion0.20 – 0.45

Want to see this with your own cases?

Schedule a 30-minute demo and walk through a real clinical case with our team.